v3.25.2
Stockholders' Equity - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 41 Months Ended
Sep. 22, 2023
May 12, 2023
May 03, 2022
Apr. 30, 2022
Jun. 30, 2025
Jun. 30, 2025
Jun. 30, 2024
May 31, 2022
Dec. 31, 2024
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Expected dividend yield           0.00% 0.00%    
Number of issued shares of restricted common stock grants         137,592 137,592 1,036,450    
Weighted Average Grant-Date Fair Value, Shares granted           $ 1.88 $ 15.02    
Weighted average grant date fair value per share of option grants           $ 0 $ 11.7    
Total unrecognized stock-based compensation cost related to stock options         $ 8,500 $ 8,500      
Sale of common stock               13,529,750  
Increase in number of authorized shares of common stock         500,000,000 500,000,000     500,000,000
Increase in number of authorized shares of preferred stock         50,000,000 50,000,000     50,000,000
Shares reserved for issuance         13,531,539 13,531,539      
Total unrecognized stock-based compensation cost related to restricted stock         $ 6,900 $ 6,900      
Sales Agreement                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Sale of common stock           1,016,950      
Net proceeds from initial public offering           $ 14,900      
Agreegate offering price             $ 14,887    
Sales agreement date   May 12, 2023              
Maximum commission percentage on gross proceeds of shares of common stock sold   3.00%              
Maximum | Sales Agreement                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Agreegate offering price   $ 100,000              
Common Stock Options                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Total unrecognized stock-based compensation cost expected to be recognized over remaining weighted-average period           1 year 10 months 24 days      
Shares reserved for issuance         2,226,181 2,226,181      
Restricted Stock                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Total unrecognized stock-based compensation cost expected to be recognized over remaining weighted-average period           1 year 7 months 6 days      
Initial Public Offering                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Public offering price per share     $ 17            
Sale of common stock     13,529,750            
Net proceeds from initial public offering     $ 209,500         $ 209,500  
Underwriting discounts, commissions and offering costs     $ 20,500            
Increase in number of authorized shares of common stock     500,000,000            
Increase in number of authorized shares of preferred stock     50,000,000            
Underwritten Public Offering                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Public offering price per share $ 12.5                
Sale of common stock 9,200,000                
Net proceeds after deducting underwriters commission $ 107,800                
Common Stock | Sales Agreement                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Sale of common stock             1,016,950    
Common Stock | Underwritten Public Offering                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Sale of common stock 1,200,000                
2021 Plan                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Plan term           ten years      
Vesting period           4 years      
Shares reserved for issuance         9,638,548 9,638,548      
Number of shares remained available for issuance under awards granted       216,849          
2022 Incentive Award Plan                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Plan term           The 2022 Plan became effective in connection with the Company’s IPO and will remain in effect until the tenth anniversary of its effective date, which will be April 28, 2032, unless earlier terminated by the Company’s board of directors. The number of shares of the Company's common stock initially available for issuance under awards granted pursuant to the 2022 Plan was the sum of (1) 4,900,000 shares of the Company’s common stock, plus (2) 216,849 shares remaining available for issuance under the 2021 Plan as of the effective date of the 2022 Plan, plus (3) any shares subject to outstanding awards under the 2021 Plan as of the effective date of the 2022 Plan that become available for issuance under the 2022 Plan thereafter in accordance with its terms.      
Shares reserved for issuance         12,537,704 12,537,704      
Number of shares remained available for issuance under awards granted       4,900,000 9,638,548 9,638,548      
Shares issuance, ending year       2032          
Percentage of shares issued from outstanding number of shares       5.00%          
2022 Employee Stock Purchase Plan                  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                  
Shares reserved for issuance       410,000          
Shares reserved for issuance         1,666,810 1,666,810      
Maximum number of shares that may be authorized in accordance with plan       10,000,000          
Shares issuance, ending year       2032          
Percentage of shares issued from outstanding number of shares       1.00%          
Purchase price of common stock, percent       85.00%